Ventyx Biosciences, Inc.
VTYX
$0.9146
$0.07859.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.60M | 7.92M | 7.91M | 8.02M | 8.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.42M | 38.55M | 35.71M | 41.77M | 50.35M |
| Operating Income | -32.42M | -38.55M | -35.71M | -41.77M | -50.35M |
| Income Before Tax | -29.35M | -35.25M | -31.95M | -38.57M | -46.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.35M | -35.25M | -31.95M | -38.57M | -46.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.35M | -35.25M | -31.95M | -38.57M | -46.75M |
| EBIT | -32.42M | -38.55M | -35.71M | -41.77M | -50.35M |
| EBITDA | -32.35M | -38.49M | -35.65M | -41.70M | -50.29M |
| EPS Basic | -0.41 | -0.50 | -0.45 | -0.62 | -0.79 |
| Normalized Basic EPS | -0.26 | -0.31 | -0.28 | -0.39 | -0.49 |
| EPS Diluted | -0.41 | -0.50 | -0.45 | -0.62 | -0.79 |
| Normalized Diluted EPS | -0.26 | -0.31 | -0.28 | -0.39 | -0.49 |
| Average Basic Shares Outstanding | 70.81M | 70.67M | 70.55M | 61.83M | 59.08M |
| Average Diluted Shares Outstanding | 70.81M | 70.67M | 70.55M | 61.83M | 59.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
